Crossmark

The role of autologous hematopoietic progenitor and cell reinfusion for intensive chemotherapy in women with poor-prognosis breast cancer. Clinical studies with ex-vivo expanded cells produced with the Aastrom Replicell® technology

Crossref DOI link: https://doi.org/10.1007/s00282-999-0078-7

Published Online: 2016-02-16

Published Print: 1999-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chabannon, C.

Novakovitch, G.

Blache, J.-L.

Olivero, S.

Camerlo, J.

Genre, D.

Maraninchi, D.

Viens, P.
License Information

Text and Data Mining valid from 1999-04-01

Document is current

Any future updates will be listed below